Chetan Pandit,Clive McCarthy,Dinesh Chikkanna,Henrik Moebitz,Mark G. Bock
申请号:
BR112012010519
公开号:
BR112012010519A2
申请日:
2010.11.02
申请国别(地区):
BR
年份:
2017
代理人:
摘要:
The present invention relates to compounds of Formula I where R1a, R1b, X, R2a, R2b, W, R3, R4, and R5 are as defined herein as well as pharmaceutically acceptable salts thereof. The compounds have been shown to act as MEK inhibitors which may be useful in the treatment of hyperproliferative diseases, like cancer and inflammation.